Skip to main content

Case Comprehensive Cancer Center

pin-crop.jpg
J. Alan Diehl appointed Deputy Director and Chief Operating Officer
J. Alan Diehl has been appointed deputy director and chief operating officer of the Case Comprehensive Cancer Center, a collaboration of Case Western Reserve University, Cleveland Clinic and University Hospitals. This newly created role will provide substantive oversight of the cancer center to…
J. Alan Diehl appointed deputy director and chief operating officer of Case Comprehensive Cancer Center
J. Alan Diehl has been appointed deputy director and chief operating officer of the Case Comprehensive Cancer Center, a collaboration of Case Western Reserve University, Cleveland Clinic and University Hospitals. This newly created role will provide substantive oversight of the cancer center to…
HSD3B1 Linked to Poor Outcomes in Low-Volume Prostate Cancer
A study led by Nima Sharifi, MD (Hearn, Jama Oncol, 2020) found the adrenal-permissive HSD3B1 allele is associated with earlier castration resistance and shorter overall survival among men with low-volume metastatic prostate cancer. These findings lay the foundation for more personalized and…
Clinical Trials in the time of COVID-19: How we are adapting and ensuring the continuance of research
The following is a message from the Associate Director for Clinical Research, Mitchell Machtay, MD and Deputy Associate Director for Clinical Research, Mikkael Sekeres, MD. Patients with cancer often turn to clinical trials because their other treatment options are limited. Though there has been a…
Deadlines extended for various cancer-focused pilot project funding opportunities
The Case Comprehensive Cancer Center has extended deadlines for a variety of open funding opportunities. Pilot project awards range from $10,000 to $180,000 and support innovative and impactful proposals that will generate key data for nationally competitive grants. View all open funding…
Funding for translational research of GI malignancies through the Case GI SPORE
The Case Comprehensive Cancer Center’s Specialized Program of Research Excellence in Gastrointestinal Malignancies (GI SPORE) invites Case Western Reserve University faculty members to submit proposals to be considered for the Career Enhancement Program (CEP) Award and Developmental Research…
Changes to Shared Resource Leadership
The Case Comprehensive Cancer Center (Case CCC) is pleased to announce that Lan Zhou, MD, PhD has accepted the role of Scientific Director of the Case Comprehensive Cancer Center (Case CCC) Hematopoietic Biorepository Cell Therapy Shared Resource. Dr. Zhou is an associate professor of pathology and…
Mian, Hwang and Gupta receive Department of Defense Translational Team Science Award
The Case Comprehensive Cancer Center (Case CCC) extends congratulations to members Omar Mian, MD, PhD, Tae Hyun Hwang, PhD and Shilpa Gupta, MD as they were recently awarded a Translational Team Science Award from the Department of Defense totaling $2.3 million. Their project is entitled,…
Message from the Director: A Week of Adjustment as We Battle COVID-19
Wednesday was a busy day in a lonely cancer center office with a total of 9 conference and Zoom calls peppered throughout the day (starting at 7:30 am), enough to have my cell phone run dry. I also saw 5 rather sick patients with cancer who needed attention and treatment decisions. Our research…
Message from the Director: Unprecedented Shift in Activities
Dear Cancer Center community, This week brings an unprecedented shift in all our activities. For our physicians caring for cancer patients, a heightened awareness of our patients' risks for COVID-19 infection and complications. For each of us, a heightened awareness of changes in social…